According to a report by Shore News Network on March 10th, New Jersey State Assemblywoman Carol A. Murphy has introduced legislation to ban the sale of tobacco products and e-cigarette devices in pharmacies and businesses with pharmacies statewide. The bill aims to amend Section 2A of the New Jersey Statutes. It is planned to take effect seven months after enactment, setting a precedent for tobacco sales regulations in the state.
The bill specifically targets the sale of cigarettes, smokeless tobacco, and any e-cigarette devices at any pharmacy or commercial entity with a pharmacy, including e-cigarettes, cigars, pipes, and their pods or components. However, there are exceptions for FDA-approved smoking cessation products and medical marijuana sold by licensed pharmacies to registered qualifying patients.
First-time violators will face a fine of no less than $250, with fines increasing to $1000 for each subsequent violation after the third offense. Additionally, the legislation also outlines disciplinary actions for pharmacies and businesses that do not comply with the regulations.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
